Solio Therapy

RF Energy-based Solutions for Pain Relief

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in December 2001 by Chuck (Shahak) Cohen, Solio Therapy operates with 1–10 employees. The company focuses on developing advanced technologies for pain relief and therapy treatments, notably receiving FDA clearance for its Alfa Plus device in July 2019.

Business overview

Solio Therapy specializes in advanced technologies for pain relief and therapy treatments, offering small, user-friendly, and affordable devices designed for safe home use. Its core product, the Solio Alfa Plus, is an FDA- and CE-approved radio frequency (RF) home device that non-invasively penetrates the skin with deep heat to increase blood circulation, accelerate tissue regeneration, and reduce inflammation, muscle aches, stiffness, and pain. The company serves the global healthcare market, particularly patients seeking solutions for chronic pain, trauma, sports injuries, and menstruation-related pain, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In July 2019, Solio Therapy's Alfa Plus device received FDA clearance, a significant regulatory milestone that validates the safety and efficacy of its radio frequency technology for pain relief. This clearance signals to investors and the medical device industry that Solio Therapy's home-use device meets rigorous health standards, paving the way for broader market adoption and commercial growth in the non-invasive pain management sector.

Company Intelligence Q&A

What is Solio Therapy's primary focus?
Solio Therapy develops advanced technologies for pain relief and therapy treatments, offering user-friendly devices for home use.
When was Solio Therapy founded?
Solio Therapy was founded in December 2001.
Who founded Solio Therapy?
Solio Therapy was founded by Chuck (Shahak) Cohen.
What is the Solio Alfa Plus device?
The Solio Alfa Plus is an FDA- and CE-approved radio frequency (RF) home device designed to relieve chronic pain, pain from trauma, sports injury, and menstruation by increasing blood circulation and accelerating tissue regeneration.
When did the Solio Alfa Plus receive FDA clearance?
The Alfa Plus by Solio received FDA clearance in July 2019.

External links